title: Modifying the ICE regimen for better prognosis small cell lung cancer--an update.
authors.forename: P M
authors.initials: PM
authors.lastname: Shevlin
authors.forename: M F
authors.initials: MF
authors.lastname: Muers
authors.forename: M D
authors.initials: MD
authors.lastname: Peake
authors.forename: H S
authors.initials: HS
authors.lastname: Hosker
authors.forename: M L
authors.initials: ML
authors.lastname: Stead
authors.forename: K M
authors.initials: KM
authors.lastname: Poulter
authors.forename: J M
authors.initials: JM
authors.lastname: Brown
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002945:Cisplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D010865:Pilot Projects; D011379:Prognosis; D015996:Survival Rate
chemical_list: D005047:Etoposide; D002945:Cisplatin; D007069:Ifosfamide